Management of HER2-Positive Early Breast Cancer. 2018

Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Vienna, Austria.

UI MeSH Term Description Entries

Related Publications

Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
November 2017, Critical reviews in oncology/hematology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
August 2020, Seminars in oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
August 2010, Current oncology (Toronto, Ont.),
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
September 2021, Asia-Pacific journal of clinical oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
March 2019, The Lancet. Oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
June 2010, Clinical journal of oncology nursing,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
December 2013, Clinical advances in hematology & oncology : H&O,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
January 2018, South Asian journal of cancer,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
December 2011, Nature reviews. Clinical oncology,
Günther Steger, and Diana Lüftner, and Herbert Stöger, and Beat Thürlimann, and Michael Untch
January 2022, Therapeutic advances in medical oncology,
Copied contents to your clipboard!